# EDGAR Filing Document

**Accession Number:** 0001753037
**File Stem:** 0001104659-23-026754
**Filing Date:** 2023-2
**Character Count:** 27656
**Document Hash:** 9659f1fd2e961e3fcd005a0cf84f8d54
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-026754.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001104659-23-026754

**CONFORMED SUBMISSION TYPE**: SC 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**GROUP MEMBERS**: 5AM OPPORTUNITIES I (GP), LLC

**GROUP MEMBERS**: 5AM OPPORTUNITIES I, L.P.

**GROUP MEMBERS**: 5AM OPPORTUNITIES II (GP), LLC

**GROUP MEMBERS**: 5AM OPPORTUNITIES II, L.P.

**GROUP MEMBERS**: 5AM PARTNERS VI, LLC

**GROUP MEMBERS**: ANDREW J. SCHWAB

**GROUP MEMBERS**: DR. KUSH PARMAR

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CinCor Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001868734
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93228
- **FILM NUMBER:** 23685989

**BUSINESS ADDRESS:**
- **STREET 1:** 230 THIRD AVE., 6TH FLOOR
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451
- **BUSINESS PHONE:** 8445311834

**MAIL ADDRESS:**
- **STREET 1:** 230 THIRD AVE., 6TH FLOOR
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** 5AM Ventures VI, L.P.
- **CENTRAL INDEX KEY:** 0001753037
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 501 2ND STREET, SUITE 350
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94107
- **BUSINESS PHONE:** (415) 993-8565

**MAIL ADDRESS:**
- **STREET 1:** 501 2ND STREET, SUITE 350
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94107

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 13D**

**Under the Securities Exchange Act of 1934<br> (Amendment No. 1)\***

**CinCor Pharma, Inc.**

(Name of Issuer)

**Common Stock, par value $0.00001 per share**

(Title of Class of Securities)

**17240Y109**

(CUSIP Number)

**5AM Venture Management, LLC**

**501 2nd Street, Suite 350**

**San Francisco, CA 94107**

**(415) 993-8565**

(Name, Address and Telephone Number of Person<br> Authorized to Receive Notices and Communications)

**February 24, 2023**

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ⌧

**Note**: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> 5AM Ventures VI, L.P. | Names of Reporting Persons<br> 5AM Ventures VI, L.P. |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> WC | Source of Funds (See Instructions)<br> WC |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> Delaware | Citizenship or Place of Organization<br> Delaware |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) PN

(1) This Schedule 13D is filed by 5AM Ventures VI, L.P. ("Ventures VI"), 5AM Partners VI, LLC ("Partners VI"),
5AM Opportunities I, L.P. ("Opportunities"), 5AM Opportunities I (GP), LLC ("Opportunities GP"), 5AM Opportunities
II, L.P. ("Opportunities II"), 5AM Opportunities II (GP), LLC ("Opportunities II GP"), Andrew J. Schwab ("Schwab")
and Dr. Kush Parmar ("Parmar" and, with Ventures VI, Partners VI, Opportunities, Opportunities GP, Opportunities II,
Opportunities II GP and Schwab, collectively, the "Reporting Persons"). The Reporting Persons expressly disclaim status as
a "group" for purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> 5AM Partners VI, LLC | Names of Reporting Persons<br> 5AM Partners VI, LLC |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> AF | Source of Funds (See Instructions)<br> AF |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> Delaware | Citizenship or Place of Organization<br> Delaware |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) OO

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> 5AM Opportunities I, L.P. | Names of Reporting Persons<br> 5AM Opportunities I, L.P. |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> WC | Source of Funds (See Instructions)<br> WC |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> Delaware | Citizenship or Place of Organization<br> Delaware |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) PN

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> 5AM Opportunities I (GP), LLC | Names of Reporting Persons<br> 5AM Opportunities I (GP), LLC |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> AF | Source of Funds (See Instructions)<br> AF |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> Delaware | Citizenship or Place of Organization<br> Delaware |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) OO

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> 5AM Opportunities II, L.P. | Names of Reporting Persons<br> 5AM Opportunities II, L.P. |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> WC | Source of Funds (See Instructions)<br> WC |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> Delaware | Citizenship or Place of Organization<br> Delaware |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) PN

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> 5AM Opportunities II (GP), LLC | Names of Reporting Persons<br> 5AM Opportunities II (GP), LLC |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> AF | Source of Funds (See Instructions)<br> AF |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> Delaware | Citizenship or Place of Organization<br> Delaware |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) OO

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> Andrew J. Schwab | Names of Reporting Persons<br> Andrew J. Schwab |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> AF | Source of Funds (See Instructions)<br> AF |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> United States | Citizenship or Place of Organization<br> United States |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) IN

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

---

| | | | |
|:---|:---|:---|:---|
| CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 | CUSIP No. 17240Y109 |
|  | 1. | Names of Reporting Persons<br> Dr. Kush Parmar | Names of Reporting Persons<br> Dr. Kush Parmar |
|  | 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) |
|  |  | (a) | ◻ |
|  |  | (b) | ⌧ (1) |
|  | 3. | SEC Use Only | SEC Use Only |
|  | 4. | Source of Funds (See Instructions)<br> AF | Source of Funds (See Instructions)<br> AF |
|  | 5. | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ | Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ◻ |
|  | 6. | Citizenship or Place of Organization<br> United States | Citizenship or Place of Organization<br> United States |

---

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 7. | Sole Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 8. | Shared Voting Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 9. | Sole Dispositive Power <br> 0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | | |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person With | 10. | Shared Dispositive Power <br> 0 |

---

11. Aggregate Amount Beneficially Owned by Each Reporting Person 0

12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) ◻

13. Percent of Class Represented by Amount in Row (11) 0.0%

14. Type of Reporting Person (See Instructions) IN

(1) This Schedule 13D is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a "group" for
purposes of this Schedule 13D.

**Explanatory Note:** This Amendment No. 1 (the "Amendment"), which amends the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on January 18, 2023 (the "Original Schedule 13D") is being filed on behalf of 5AM Ventures VI, L.P. ("Ventures VI"), 5AM Partners VI, LLC ("Partners VI"), 5AM Opportunities I, L.P. ("Opportunities"), 5AM Opportunities I (GP), LLC ("Opportunities GP"), 5AM Opportunities II, L.P. ("Opportunities II"), 5AM Opportunities II (GP), LLC ("Opportunities II GP"), Andrew J. Schwab ("Schwab") and Dr. Kush Parmar ("Parmar" and, with Ventures VI, Partners VI, Opportunities, Opportunities GP, Opportunities II, Opportunities II GP and Schwab, collectively, the "Reporting Persons") in respect of the Common Stock, $0.00001 par value ("Common Stock") of CinCor Pharma, Inc., a Delaware corporation (the "Issuer" or "CinCor"). This Amendment is being filed for the purpose of reporting the disposition of the securities of the Issuer by the Reporting Persons in connection with the closing of the Merger (as defined below). The Original Schedule 13D is hereby amended and supplemented to the extent hereinafter expressly set forth and, except as amended and supplemented hereby, the Original Schedule 13D remains in full force and effect. All capitalized terms used in this Amendment but not defined herein shall have the meanings ascribed thereto in the Original Schedule 13D.

**Item 4.** **Purpose of Transaction**

*Item 4 of the Original Schedule 13D is hereby amended and supplemented by adding the following paragraph at the end of Item 4:*

On February 24, 2023, pursuant to the Merger Agreement, Purchaser completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for (i) $26.00 per Share in cash (the "Cash Amount"), plus (ii) one contingent value right (each, a "CVR") per Share representing the right to receive a contingent payment of $10.00 per share, in cash, upon the achievement of a specified milestone by December 31, 2033 (the Cash Amount plus one CVR, collectively, the "Offer Price"), in each case, without interest, subject to any applicable withholding taxes. Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Offer Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Offer Price.

**Item 5.** **Interest in Securities of the Issuer**

(a) – (b). The following information with respect to the ownership of the Common Stock of the Issuer by the persons filing this statement on Schedule 13D is provided as of February 28, 2023:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Reporting Persons** | **Shares Held<br> Directly** | **Sole<br> Voting<br> Power** | **Shared<br> Voting<br> Power** | **Sole<br> Dispositive<br> Power** | **Shared<br> Dispositive<br> Power** | **Beneficial<br> Ownership** | **Percentage<br> of Class** |
| Ventures VI | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Partners VI | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Opportunities | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Opportunities GP | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Opportunities II | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Opportunities II GP | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Schwab | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Parmar | 0 | 0 | 0 | 0 | 0 | 0 | 0.0% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) None of the Reporting Persons has effected any transactions
in shares of the Issuer's Common Stock during the last 60 days.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or any proceeds from the sale of, the shares of Common Stock beneficially owned by any
of the Reporting Persons.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) The Reporting Persons ceased to be the beneficial owners of
more than five percent of the Common Stock on February 24, 2023.

**Item 7.** **Material to be Filed as Exhibits**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Joint Filing Agreement, dated January 18, 2023 (incorporated by reference to the Original Schedule
13D, filed on January 18, 2023).

**Signature**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 28, 2023

---

| | |
|:---|:---|
| **5AM Ventures VI, L.P.** | **5AM Ventures VI, L.P.** |
| By: | 5AM Partners VI, LLC |
| its | General Partner |
| By: | /s/ Andrew J. Schwab |
|  | Name: Andrew J. Schwab |
|  | Title: Managing Member |
| **5AM Partners VI, LLC** | **5AM Partners VI, LLC** |
| By: | /s/ Andrew J. Schwab |
|  | Name: Andrew J. Schwab |
|  | Title: Managing Member |
| **5AM Opportunities I, L.P.** | **5AM Opportunities I, L.P.** |
| By: | 5AM Opportunities I (GP), LLC |
| its | General Partner |
| By: | /s/ Andrew J. Schwab |
|  | Name: Andrew J. Schwab |
|  | Title: Managing Member |
| **5AM Opportunities I (GP), LLC** | **5AM Opportunities I (GP), LLC** |
| By: | /s/ Andrew J. Schwab |
|  | Name: Andrew J. Schwab |
|  | Title: Managing Member |
| **5AM Opportunities II, L.P.** | **5AM Opportunities II, L.P.** |
| By: | 5AM Opportunities II (GP), LLC |
| its | General Partner |
| By: | /s/ Andrew J. Schwab |
|  | Name: Andrew J. Schwab |
|  | Title: Managing Member |
| **5AM Opportunities II (GP), LLC** | **5AM Opportunities II (GP), LLC** |
| By: | /s/ Andrew J. Schwab |
|  | Name: Andrew J. Schwab |
|  | Title: Managing Member |
| /s/ Andrew J. Schwab | /s/ Andrew J. Schwab |
| Andrew J. Schwab | Andrew J. Schwab |
| /s/ Dr. Kush Parmar | /s/ Dr. Kush Parmar |
| Dr. Kush Parmar | Dr. Kush Parmar |

---

---

| | |
|:---|:---|
| | **ATTENTION** |
| **Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).** | **Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).** |

---